BCMA-targeted CAR T-Cell Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BCMA-targeted CAR T-Cell Injection, covering 2026-03-09 to 2026-03-09. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma [EARLY_Phase 1]